Related Content
- In the PressJanuary 27, 2023
Top 5 Compliance Issues for Medtech Firms Transitioning To Data-Enabled Solutions (MedCity News)
- Goodwin InsightsJanuary 25, 2023
In the Metaverse, Existing Healthcare Rules Apply
- AlertJanuary 10, 2023
Deadline Approaching for Reporting 2022 ISO Exercises and ESPP Transfers
- AlertJanuary 4, 2023
New Appropriations Bill Reforms Antitrust Laws and Modifies HSR Fees
- AlertDecember 16, 2022
SEC Adopts Amendments to Rules Governing Rule 10b5-1 Trading Plans
- AlertDecember 13, 2022
SEC Staff Risk Alert Criticizes Broker-Dealer Reports on Best Execution and Payment for Order Flow
- AlertDecember 6, 2022
EU Standard Contractual Clauses Need Replacing by December 27, 2022
- Goodwin InsightsNovember 22, 2022
London’s Efforts to Facilitate Secondary Capital Raisings Continue: UK Pre-emption Group Issues Updated Statement of Principles
- In the PressJanuary 26, 2023
UK Biotech Financing Report 2022 (UK BioIndustry Association)
- In the PressJanuary 25, 2023
Phila. Law Firm Leaders Find Opportunity, Not Threat, in Goodwin Arrival (Law.com)
- In the PressJanuary 24, 2023
Top 5 FDA Considerations for Medtech-Enabled Data Platforms (MedCity News)
- In the PressJanuary 23, 2023
Goodwin Officially Enters Philadelphia with 14 Partners Across 3 Practice Groups (Philadelphia Business Journal)
- In the PressJanuary 23, 2023
Goodwin Chairman Sees Big Opportunity and Growth Potential in 'Exciting' Philadelphia Market (Philadelphia Business Journal)
- In the PressJanuary 23, 2023
Deal Watch: Law Firms Seek Growth with Other Business Drivers (Law.com)
- Press ReleaseJanuary 23, 2023
MW Investment B.V. to Acquire Meltwater
- In the PressJanuary 20, 2023
Goodwin Adds IP Litigator In San Francisco (Law360)